Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3-kinase gamma (PI3Kγ) is a lipid kinase and the only member of class IB PI3Ks. It plays a crucial role in immune cell signaling, regulating chemotaxis, cytokine release, and ROS generation. PI3Kγ exists as a heterodimer, composed of a catalytic subunit (p110γ) and a regulatory subunit (p101 or p84/p87). It is activated downstream of GPCRs and other receptor types, making it a key therapeutic target for inflammatory diseases and cancer.
PI3Kγ phosphorylates phosphatidylinositol 4,5-bisphosphate [PI(4,5)P₂] to generate phosphatidylinositol 3,4,5-trisphosphate [PIP₃], a key second messenger in cell signaling. Inhibitors block this phosphorylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-Kinase Gamma Subunit (PI3Kγ).